GlassScriptPhysician profile
Tiffani M Middleton
NPI 1447435227
$860.45
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $14.59 · 2021: $227 · 2022: $249 · 2023: $255 · 2024: $115.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $370.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $369.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon US, LLC | $268.60 | 2023-2024 | Enseal, Enseal X1, Stratafix |
| Myovant Sciences INC. | $118.20 | 2021-2022 | |
| Meditrina | $91.36 | 2022 | |
| Abbvie INC. | $88.46 | 2022 | |
| Evofem Biosciences, INC. | $49.28 | 2021-2022 | |
| Organon LLC | $44.56 | 2021-2023 | Nexplanon |
| Medicem INC. | $40.89 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $32.99 | 2024 | Fruzaqla |
| Coopersurgical, INC. | $21.59 | 2023 | Mara Console |
| Hologic Sales and Service, LLC | $19.33 | 2023 | Acessa Provu System |
| Avion Pharmaceuticals | $17.54 | 2021 | |
| Smith+Nephew, INC. | $16.53 | 2021 | |
| Merck Sharp & Dohme LLC | $16.22 | 2022 | |
| Agile Therapeutics, INC. | $15.45 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $14.59 | 2020 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alydia Health | $4.86 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tiffani Middleton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.